Negative HER-2 by Immunohistochemistry Correlates Strongly with Negative HER-2 Amplification by Fluorescence In Situ Hybridization in Triple Negative Breast Cancers

被引：0
|
作者：
Xian, R. [1 ]
Raghunath, P. [1 ]
Paul, Z. [1 ]
机构：
[1] Hosp Univ Penn, Philadelphia, PA 19104 USA
来源：
MODERN PATHOLOGY | 2013年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
307
引用
收藏
页码：75A / 76A
页数：2
相关论文
共 50 条
  • [31] Pathological Axillary Lymph Node Status in HER-2 Receptor Positive and Negative Breast Cancers
    Jeon Hor Chen
    Garima Agrawal
    P. Carpenter
    Rita S. Mehta
    Orhan Nalcioglu
    Min-Ying Su
    Annals of Surgical Oncology, 2008, 15 : 941 - 942
  • [32] HER-2 in node-negative breast carcinoma: prognostic significance
    Rampaul, RS
    Pinder, SE
    Bell, JA
    Wencyk, P
    Macmillan, DM
    Blamey, RW
    Robertson, JFR
    Ellis, IO
    BRITISH JOURNAL OF SURGERY, 2001, 88 : 6 - 7
  • [33] IMPLICATIONS OF EXTRACAPSULAR NODAL METASTASES FOR PROGNOSIS IN HER-2 RECEPTOR POSITIVE AND NEGATIVE BREAST CANCERS
    Maksimovic, S.
    ANNALS OF ONCOLOGY, 2010, 21 : 36 - 36
  • [34] HER-2 Positive and p53 Negative Breast Cancers are Associated With Poor Prognosis
    Al-azawi, Dhafir
    Leong, Sum
    Wong, Limy
    Kay, Elaine
    Hill, Arnold D. K.
    Young, Leonie
    CANCER INVESTIGATION, 2011, 29 (05) : 365 - 369
  • [35] Pathological axillary lymph node status in HER-2 receptor positive and negative breast cancers
    Chen, Jeon Hor
    Agrawal, Garima
    Carpenter, P.
    Mehta, Rita S.
    Nalcioglu, Orhan
    Su, Min-Ying
    ANNALS OF SURGICAL ONCOLOGY, 2008, 15 (03) : 941 - 942
  • [36] Shorter telomeres in luminal B, HER-2 and triple-negative breast cancer subtypes
    Heaphy, Christopher M.
    Subhawong, Andrea Proctor
    Gross, Amy L.
    Konishi, Yuko
    Kouprina, Nina
    Argani, Pedram
    Visvanathan, Kala
    Meeker, Alan K.
    MODERN PATHOLOGY, 2011, 24 (02) : 194 - 200
  • [37] Triple-negative (ER, PgR, HER-2/neu) breast cancer in Indian women
    Patil, Vinayak W.
    Singhai, Rajeev
    Patil, Amit V.
    Gurav, Prakash D.
    BREAST CANCER-TARGETS AND THERAPY, 2011, 3 : 9 - 19
  • [38] C-myc, not HER-2/neu, correlates with early recurrence of node-negative breast cancers.
    Schlotter, CM
    Vogt, U
    Bosse, U
    Wassmann, K
    BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (03) : 262 - 262
  • [39] IMMUNOHISTOCHEMICAL HER-2/NEU EXPRESSION WITH GENE AMPLIFICATION BY FLUORESCENCE IN SITU HYBRIDIZATION FOR ASSESSMENT IN BREAST CARCINOMAS
    Moatter, Tariq
    Zeeshan-ud-din
    Khilji, Zahida Latif
    Murad, Farzana
    Kayani, Naila
    Pervez, Shahid
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2007, 17 (12): : 726 - 730
  • [40] Evaluation of HER-2 status in breast carcinoma by fluorescence in situ hybridization and immunohistachemistry
    Ogura H.
    Akiyama F.
    Kasumi F.
    Kazui T.
    Sakamoto G.
    Breast Cancer, 2003, 10 (3) : 234 - 240
12345